0

a--up

none

1

a--up

none

1

a--up

none

2

a--up

none

3

a--up

none

4

a--up

none

© 2025 ISOMORPHIC LABS

Isomorphic Labs announces $600m external investment round

1

a--up

none

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

a--up

2

2

1

Isomorphic Labs Colleagues

Meet our team: Agnieszka & Michael

Isomorphic Labs announces Novartis collaboration expansion

Using our state-of-the-art AI models to power drug design

Isomorphic Labs and the Google DeepMind AlphaFold team

AlphaFold 3 predicts the structure and interactions of all of life’s molecules

Max Jaderberg, Adrian Stecula, Pascal Savy

Rational drug design with AlphaFold 3

Isomorphic Labs

In conversation with… Colin Murdoch, Isomorphic Labs’ first President

Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations

The Isomorphic Labs team and Google DeepMind AlphaFold team

A glimpse of the next generation of AlphaFold

Max Jaderberg, Director of Machine Learning

Modelling the invisible world of Molecular Biology with Machine Learning

Kate Parkyn, Talent Director

How to get a job at Isomorphic Labs

Isomorphic Labs Colleagues

Why I: Isomorphic Labs colleagues share what attracted them and inspires their work

Isomorphic Labs

Isomorphic Labs Announces New Lausanne Location

Miles Congreve, Chief Scientific Officer

“It's both humbling and exciting to adopt a beginner’s mindset” - Having permission to be wrong

Isomorphic Labs Colleagues

Why I: Isomorphic Labs colleagues share why they joined the company

Caroline Low, Distinguished Researcher

Breaking barriers and building bridges with purpose

Sergei Yakneen, Chief Technology Officer

“Once in a lifetime - or never” - Reflections from year one at Isomorphic Labs

Isomorphic Labs announces new Scientific Advisory Board

Isomorphic Labs announces first phase of management team

Introducing Isomorphic Labs